Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Thomas Jefferson University at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Thomas Jefferson University brings 1 presentation to ASH 2026 in New Orleans. Its program spans new sickle cell disease treatments and artificial intelligence in the clinic. It covers gene-based therapies and activators for sickle cell disease, and AI tools that streamline practice workflows.

OrganizationASH 2026 Attendance
jefferson.edu
Universities & research institutes
Private university and academic health system in Philadelphia, Pennsylvania.
Symposium
Fri Dec 11
7:00am–10:00am
A Hematologist’s Guide to the Sickle Cell Disease Revolution: Genes, Activators, and Beyond
Approved and emerging gene therapies and new pyruvate kinase activators for sickle cell disease, and how to match patients to each and refer them.
Convention Center · Hall C
Red cells · Cell & gene
Talk

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Thomas Jefferson University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction